CVS Health vs Walgreens Boots Alliance
CVS Health holds the stronger position because its combined pharmacy, insurance, and drug-benefit business is harder for a rival to copy and faces lighter direct competitive pressure than Walgreens.
CVS Health
Pharmacy, insurance, and drug benefits giant with 9,000 stores and 88M PBM members
Walgreens Boots Alliance
Walgreens runs thousands of US pharmacies and health clinics, now owned by private equity firm Sycamore Partners.
Dimension by dimension
| Dimension | CVS Health | Walgreens Boots Alliance |
|---|---|---|
| Staying power of the core product | CVS's mix of pharmacy, insurance, and drug-benefit management spans multiple integrated business lines, making it unlikely to be absorbed by AI tools. | Walgreens is only a pharmacy and clinic operator, leaving parts of its business more exposed to AI-driven substitution. |
| Exposure to AI | CVS's product is described as unlikely to be replaced by AI. | Walgreens is described as partly exposed, meaning AI tools could take over parts of what it offers. |
| How easily a giant could copy them | CVS is harder to replicate quickly, largely due to owning insurance and drug-benefit pieces together. | Walgreens is easier to replicate, since it lacks the same combined structure. |
| Pressure from rivals | CVS faces competition from Cigna's Express Scripts and Amazon Pharmacy but leads Walgreens in prescription revenue ($119.0B vs $90.8B) and share (about 21% vs under 20%). | Walgreens faces heavier direct pressure than CVS, trailing in prescription revenue ($90.8B vs $119.0B) and share (under 20% vs about 21%), while big-box and online pharmacy use keeps rising. |
| Financial footing | CVS posted $402.067 billion in FY2025 revenue and $100.43 billion in Q1 2026 revenue, with FY2026 adjusted earnings guidance of $7.00 to $7.20 per share. | Walgreens grew Q3 FY2025 sales 7.2% to $39.0 billion but posted a $175 million net loss that same quarter, on FY2024 revenue of $147.7 billion. |
| Overall standing | CVS's combined business lines and FY2025 revenue of $402.067 billion support its current market position, assessed July 2026. | Walgreens's Q3 FY2025 net loss of $175 million alongside 7.2% sales growth points to an unsettled outlook, assessed July 2026. |
Questions people ask
- Is CVS or Walgreens better positioned for the AI era?
- CVS is in a stronger position because its pharmacy, insurance, and drug-benefit pieces work together in a way that is hard to copy and unlikely to be replaced by AI. Walgreens runs mainly pharmacies and clinics, which leaves it more exposed to both AI tools and competitive copying.
- How do CVS and Walgreens compare financially?
- CVS reported $402.067 billion in FY2025 revenue and gave FY2026 adjusted earnings guidance of $7.00 to $7.20 per share. Walgreens grew Q3 FY2025 sales 7.2% to $39.0 billion but still posted a $175 million net loss in that quarter.
- Could a tech giant like Amazon replace CVS or Walgreens?
- Walgreens is marked as likely to be copied by a giant, while CVS is marked as blocked from that kind of copying. This is tied to CVS controlling insurance and drug-benefit management alongside its pharmacies, something Walgreens does not have.
- Who owns Walgreens now and does that matter here?
- Walgreens is now owned by the private equity firm Sycamore Partners. That ownership change is separate from the competitive pressures described here, which come mainly from CVS's stronger prescription share and rising big-box and online pharmacy competition.
Other comparisons with these companies